Literature DB >> 1582301

Long-term survival in aged patients with corrected transposition of the great arteries.

U Ikeda1, M Furuse, O Suzuki, K Kimura, H Sekiguchi, K Shimada.   

Abstract

Corrected transposition of the great arteries is a rare condition, and few patients with this abnormality survive past 50 years of age because of associated congenital defects or the subsequent development of atrioventricular valvular insufficiency or heart block or both. We describe four men with uncomplicated C-TGA. Our patients are of interest for the following reasons: (a) their condition is very rare; (b) the diagnosis of C-TGA traditionally has been verified through invasive cardiac catheterization procedures; however, in our latest two patients, recently developed noninvasive diagnostic techniques played the decisive role in the diagnosis of C-TGA; (c) in these modalities, they presented as a "natural experimental model" that the right ventricle submitted to a high systemic pressure load is capable of increasing muscle mass over long-term adaptation. Our four patients illustrate that patients with C-TGA, even with the associated cardiac anomalies, may live a normal life span with proper management.

Entities:  

Mesh:

Year:  1992        PMID: 1582301     DOI: 10.1378/chest.101.5.1382

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Atrioventricular and ventriculoarterial discordance (congenitally corrected transposition of the great arteries): echocardiographic features, associations, and outcome in 34 fetuses.

Authors:  G Sharland; R Tingay; A Jones; J Simpson
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

2.  Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up.

Authors:  S Fratz; M Hauser; F M Bengel; A Hager; H Kaemmerer; M Schwaiger; J Hess; H C Stern
Journal:  Heart       Date:  2006-06-14       Impact factor: 5.994

3.  Feature-Tracking MRI Fractal Analysis of Right Ventricular Remodeling in Adults with Congenitally Corrected Transposition of the Great Arteries.

Authors:  Masateru Kawakubo; Michinobu Nagao; Umiko Ishizaki; Yumi Shiina; Kei Inai; Yuzo Yamasaki; Masami Yoneyama; Shuji Sakai
Journal:  Radiol Cardiothorac Imaging       Date:  2019-10-31

4.  Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteries.

Authors:  M Hauser; F M Bengel; A Hager; A Kuehn; S G Nekolla; H Kaemmerer; M Schwaiger; J Hess
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

5.  Long term follow up after surgery in congenitally corrected transposition of the great arteries with a right ventricle in the systemic circulation.

Authors:  Ad J J C Bogers; Stuart J Head; Peter L de Jong; Maarten Witsenburg; Arie Pieter Kappetein
Journal:  J Cardiothorac Surg       Date:  2010-09-28       Impact factor: 1.637

6.  Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries.

Authors:  T S Hornung; E J Bernard; E T Jaeggi; R B Howman-Giles; D S Celermajer; R E Hawker
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

7.  Incidental congenitally corrected transposition of the great arteries (ccTGA) in an adult with suspected coronary artery disease: review on radiological features and pathophysiology.

Authors:  Khairil Amir Sayuti; Mohd Yadie Syazwan Bin Azizi
Journal:  BMJ Case Rep       Date:  2020-04-22

8.  Long-Term Outcomes of Tricuspid Valve Surgery in Patients With Congenitally Corrected Transposition of the Great Arteries.

Authors:  Long Deng; Jianping Xu; Yajie Tang; Hansong Sun; Sheng Liu; Yunhu Song
Journal:  J Am Heart Assoc       Date:  2018-03-16       Impact factor: 5.501

9.  A case of pseudo-hypertrophic cardiomyopathy: a congenital heart disease.

Authors:  Riccardo Ieva; Michele Correale; Matteo Di Biase
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.